Your browser doesn't support javascript.
loading
Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysis.
Fan, Wenzhe; Zhu, Bowen; Yue, Shufan; Zheng, Xinlin; Zou, Xinhua; Li, Fuliang; Qiao, Liangliang; Wu, Yanqin; Xue, Miao; Wang, Hongyu; Tang, Yiyang; Li, Jiaping.
Afiliación
  • Fan W; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Zhu B; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Yue S; Department of Ultrasonic, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Zheng X; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Zou X; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Li F; Liver and Gall Surgical Department, Gaozhou People's Hospital, Gaozhou, China.
  • Qiao L; Department of Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Wu Y; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Xue M; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Wang H; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Tang Y; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
  • Li J; Department of Interventional Oncology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
Cancer Med ; 12(1): 61-72, 2023 01.
Article en En | MEDLINE | ID: mdl-35698292
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos